Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Patients need long-term care after bariatric surgery to manage potential nutritional and metabolic issues.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Dermatologists need to understand hair products to treat hair and scalp issues better.

Some herbal therapies may help with skin conditions, but more research is needed to confirm their safety and effectiveness.

Finasteride for hair loss can cause long-lasting sexual side effects like low libido and erectile dysfunction.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Some medicinal plants can help heal wounds and may lead to new treatments.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.